GSK vs NDSN · P/E 13, $103.31B cap vs P/E 31, rev $817.7M
GlaxoSmithKline PLC ADR (GSK) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported NDSN revenue for 2026-07-31 was $817.7M. Net income was $152.8M. Revenue was down 42.0% from 2026-04-30 to 2026-07-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the GSK and NDSN stock pages for the full models.
Not investment advice.